Beijing LabTech Instruments (688056.SH) has announced a forecasted increase, with an estimated net profit of 40 to 43 million yuan in 2024, an increase of 45.12% to 56.01% year-on-year.
Lebertech (688056.SH) announced that the company is expected to achieve attributable to the parent company in 2024...
Beijing LabTech Instruments (688056.SH) announced that the company is expected to achieve a net profit attributable to the owners of the parent company of 40 to 43 million yuan in the year 2024. Compared with the same period last year (legally disclosed data), this represents an increase of 12.4375 million to 15.4375 million yuan, an increase of 45.12% to 56.01% year-on-year.
Related Articles

Hong Kong stocks rise as Beijing vows stronger tech self-reliance and domestic support

US Stock Market Move | Teladoc Health (TDOC.US) rises more than 9% after receiving a target price increase from Bank of America.

US Stock Market Move | Alphabet Inc. Class C (GOOGL.US) rose nearly 3%, deeply binding with Anthropic to build a computational moat.
Hong Kong stocks rise as Beijing vows stronger tech self-reliance and domestic support

US Stock Market Move | Teladoc Health (TDOC.US) rises more than 9% after receiving a target price increase from Bank of America.

US Stock Market Move | Alphabet Inc. Class C (GOOGL.US) rose nearly 3%, deeply binding with Anthropic to build a computational moat.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


